Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder

.

Source: World Journal of Biological Psychiatry - March 8, 2022 Category: Psychiatry Authors: Thomas Vanicek Jakob Unterholzner Rupert Lanzenberger Angela Naderi-Heiden Siegfried Kasper Nicole Praschak-Rieder Source Type: research